Product NDC: | 13537-027 |
Proprietary Name: | LBEL |
Non Proprietary Name: | Ensulizole, Octinoxate, Octisalate, Oxybenzone, and Titanium dioxide |
Active Ingredient(s): | .03; .075; .05; .06; .039 g/mL; g/mL; g/mL; g/mL; g/mL & nbsp; Ensulizole, Octinoxate, Octisalate, Oxybenzone, and Titanium dioxide |
Administration Route(s): | TOPICAL |
Dosage Form(s): | LOTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 13537-027 |
Labeler Name: | Ventura Corporation Ltd. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part352 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20110810 |
Package NDC: | 13537-027-03 |
Package Description: | 1 BOTTLE in 1 BOX (13537-027-03) > 5 mL in 1 BOTTLE (13537-027-02) |
NDC Code | 13537-027-03 |
Proprietary Name | LBEL |
Package Description | 1 BOTTLE in 1 BOX (13537-027-03) > 5 mL in 1 BOTTLE (13537-027-02) |
Product NDC | 13537-027 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Ensulizole, Octinoxate, Octisalate, Oxybenzone, and Titanium dioxide |
Dosage Form Name | LOTION |
Route Name | TOPICAL |
Start Marketing Date | 20110810 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | Ventura Corporation Ltd. |
Substance Name | ENSULIZOLE; OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE |
Strength Number | .03; .075; .05; .06; .039 |
Strength Unit | g/mL; g/mL; g/mL; g/mL; g/mL |
Pharmaceutical Classes |